Abstract
Summary
LPI (LP Information)' newest research report, the “BioMEMS Devices Industry Forecast” looks at past sales and reviews total world BioMEMS Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected BioMEMS Devices sales for 2023 through 2029. With BioMEMS Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world BioMEMS Devices industry.
This Insight Report provides a comprehensive analysis of the global BioMEMS Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on BioMEMS Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global BioMEMS Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for BioMEMS Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global BioMEMS Devices.
The global BioMEMS Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for BioMEMS Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for BioMEMS Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for BioMEMS Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key BioMEMS Devices players cover Honeywell International, Omron Corporation, Analog Devices, Perkinelmer Inc, Abbott, STmicroelectronics, Freescale Semiconductor, All Sensors Corporation and TE Connectivity, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of BioMEMS Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
MEMS Sensors
Microfluidics
Other
Segmentation by application
Medical Devices
Home Care Devices
In Vitro Diagnostics
Pharmaceutical & Biological Research
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Honeywell International
Omron Corporation
Analog Devices
Perkinelmer Inc
Abbott
STmicroelectronics
Freescale Semiconductor
All Sensors Corporation
TE Connectivity
First Sensor AG
Capitalbio Corporation
Teledyne Technologies
Silicon Microstructures
Micralyne Inc
Knowles Corporation
Integrated Sensing Systems
Key Questions Addressed in this Report
What is the 10-year outlook for the global BioMEMS Devices market?
What factors are driving BioMEMS Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do BioMEMS Devices market opportunities vary by end market size?
How does BioMEMS Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
This Insight Report provides a comprehensive analysis of the global BioMEMS Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on BioMEMS Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global BioMEMS Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for BioMEMS Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global BioMEMS Devices.
The global BioMEMS Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for BioMEMS Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for BioMEMS Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for BioMEMS Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key BioMEMS Devices players cover Honeywell International, Omron Corporation, Analog Devices, Perkinelmer Inc, Abbott, STmicroelectronics, Freescale Semiconductor, All Sensors Corporation and TE Connectivity, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of BioMEMS Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
MEMS Sensors
Microfluidics
Other
Segmentation by application
Medical Devices
Home Care Devices
In Vitro Diagnostics
Pharmaceutical & Biological Research
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Honeywell International
Omron Corporation
Analog Devices
Perkinelmer Inc
Abbott
STmicroelectronics
Freescale Semiconductor
All Sensors Corporation
TE Connectivity
First Sensor AG
Capitalbio Corporation
Teledyne Technologies
Silicon Microstructures
Micralyne Inc
Knowles Corporation
Integrated Sensing Systems
Key Questions Addressed in this Report
What is the 10-year outlook for the global BioMEMS Devices market?
What factors are driving BioMEMS Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do BioMEMS Devices market opportunities vary by end market size?
How does BioMEMS Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global BioMEMS Devices Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for BioMEMS Devices by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for BioMEMS Devices by Country/Region, 2018, 2022 & 2029
2.2 BioMEMS Devices Segment by Type
2.2.1 MEMS Sensors
2.2.2 Microfluidics
2.2.3 Other
2.3 BioMEMS Devices Sales by Type
2.3.1 Global BioMEMS Devices Sales Market Share by Type (2018-2023)
2.3.2 Global BioMEMS Devices Revenue and Market Share by Type (2018-2023)
2.3.3 Global BioMEMS Devices Sale Price by Type (2018-2023)
2.4 BioMEMS Devices Segment by Application
2.4.1 Medical Devices
2.4.2 Home Care Devices
2.4.3 In Vitro Diagnostics
2.4.4 Pharmaceutical & Biological Research
2.4.5 Other
2.5 BioMEMS Devices Sales by Application
2.5.1 Global BioMEMS Devices Sale Market Share by Application (2018-2023)
2.5.2 Global BioMEMS Devices Revenue and Market Share by Application (2018-2023)
2.5.3 Global BioMEMS Devices Sale Price by Application (2018-2023)
3 Global BioMEMS Devices by Company
3.1 Global BioMEMS Devices Breakdown Data by Company
3.1.1 Global BioMEMS Devices Annual Sales by Company (2018-2023)
3.1.2 Global BioMEMS Devices Sales Market Share by Company (2018-2023)
3.2 Global BioMEMS Devices Annual Revenue by Company (2018-2023)
3.2.1 Global BioMEMS Devices Revenue by Company (2018-2023)
3.2.2 Global BioMEMS Devices Revenue Market Share by Company (2018-2023)
3.3 Global BioMEMS Devices Sale Price by Company
3.4 Key Manufacturers BioMEMS Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers BioMEMS Devices Product Location Distribution
3.4.2 Players BioMEMS Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for BioMEMS Devices by Geographic Region
4.1 World Historic BioMEMS Devices Market Size by Geographic Region (2018-2023)
4.1.1 Global BioMEMS Devices Annual Sales by Geographic Region (2018-2023)
4.1.2 Global BioMEMS Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic BioMEMS Devices Market Size by Country/Region (2018-2023)
4.2.1 Global BioMEMS Devices Annual Sales by Country/Region (2018-2023)
4.2.2 Global BioMEMS Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas BioMEMS Devices Sales Growth
4.4 APAC BioMEMS Devices Sales Growth
4.5 Europe BioMEMS Devices Sales Growth
4.6 Middle East & Africa BioMEMS Devices Sales Growth
5 Americas
5.1 Americas BioMEMS Devices Sales by Country
5.1.1 Americas BioMEMS Devices Sales by Country (2018-2023)
5.1.2 Americas BioMEMS Devices Revenue by Country (2018-2023)
5.2 Americas BioMEMS Devices Sales by Type
5.3 Americas BioMEMS Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC BioMEMS Devices Sales by Region
6.1.1 APAC BioMEMS Devices Sales by Region (2018-2023)
6.1.2 APAC BioMEMS Devices Revenue by Region (2018-2023)
6.2 APAC BioMEMS Devices Sales by Type
6.3 APAC BioMEMS Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe BioMEMS Devices by Country
7.1.1 Europe BioMEMS Devices Sales by Country (2018-2023)
7.1.2 Europe BioMEMS Devices Revenue by Country (2018-2023)
7.2 Europe BioMEMS Devices Sales by Type
7.3 Europe BioMEMS Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa BioMEMS Devices by Country
8.1.1 Middle East & Africa BioMEMS Devices Sales by Country (2018-2023)
8.1.2 Middle East & Africa BioMEMS Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa BioMEMS Devices Sales by Type
8.3 Middle East & Africa BioMEMS Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of BioMEMS Devices
10.3 Manufacturing Process Analysis of BioMEMS Devices
10.4 Industry Chain Structure of BioMEMS Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 BioMEMS Devices Distributors
11.3 BioMEMS Devices Customer
12 World Forecast Review for BioMEMS Devices by Geographic Region
12.1 Global BioMEMS Devices Market Size Forecast by Region
12.1.1 Global BioMEMS Devices Forecast by Region (2024-2029)
12.1.2 Global BioMEMS Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global BioMEMS Devices Forecast by Type
12.7 Global BioMEMS Devices Forecast by Application
13 Key Players Analysis
13.1 Honeywell International
13.1.1 Honeywell International Company Information
13.1.2 Honeywell International BioMEMS Devices Product Portfolios and Specifications
13.1.3 Honeywell International BioMEMS Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Honeywell International Main Business Overview
13.1.5 Honeywell International Latest Developments
13.2 Omron Corporation
13.2.1 Omron Corporation Company Information
13.2.2 Omron Corporation BioMEMS Devices Product Portfolios and Specifications
13.2.3 Omron Corporation BioMEMS Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Omron Corporation Main Business Overview
13.2.5 Omron Corporation Latest Developments
13.3 Analog Devices
13.3.1 Analog Devices Company Information
13.3.2 Analog Devices BioMEMS Devices Product Portfolios and Specifications
13.3.3 Analog Devices BioMEMS Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Analog Devices Main Business Overview
13.3.5 Analog Devices Latest Developments
13.4 Perkinelmer Inc
13.4.1 Perkinelmer Inc Company Information
13.4.2 Perkinelmer Inc BioMEMS Devices Product Portfolios and Specifications
13.4.3 Perkinelmer Inc BioMEMS Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Perkinelmer Inc Main Business Overview
13.4.5 Perkinelmer Inc Latest Developments
13.5 Abbott
13.5.1 Abbott Company Information
13.5.2 Abbott BioMEMS Devices Product Portfolios and Specifications
13.5.3 Abbott BioMEMS Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Abbott Main Business Overview
13.5.5 Abbott Latest Developments
13.6 STmicroelectronics
13.6.1 STmicroelectronics Company Information
13.6.2 STmicroelectronics BioMEMS Devices Product Portfolios and Specifications
13.6.3 STmicroelectronics BioMEMS Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 STmicroelectronics Main Business Overview
13.6.5 STmicroelectronics Latest Developments
13.7 Freescale Semiconductor
13.7.1 Freescale Semiconductor Company Information
13.7.2 Freescale Semiconductor BioMEMS Devices Product Portfolios and Specifications
13.7.3 Freescale Semiconductor BioMEMS Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Freescale Semiconductor Main Business Overview
13.7.5 Freescale Semiconductor Latest Developments
13.8 All Sensors Corporation
13.8.1 All Sensors Corporation Company Information
13.8.2 All Sensors Corporation BioMEMS Devices Product Portfolios and Specifications
13.8.3 All Sensors Corporation BioMEMS Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 All Sensors Corporation Main Business Overview
13.8.5 All Sensors Corporation Latest Developments
13.9 TE Connectivity
13.9.1 TE Connectivity Company Information
13.9.2 TE Connectivity BioMEMS Devices Product Portfolios and Specifications
13.9.3 TE Connectivity BioMEMS Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 TE Connectivity Main Business Overview
13.9.5 TE Connectivity Latest Developments
13.10 First Sensor AG
13.10.1 First Sensor AG Company Information
13.10.2 First Sensor AG BioMEMS Devices Product Portfolios and Specifications
13.10.3 First Sensor AG BioMEMS Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 First Sensor AG Main Business Overview
13.10.5 First Sensor AG Latest Developments
13.11 Capitalbio Corporation
13.11.1 Capitalbio Corporation Company Information
13.11.2 Capitalbio Corporation BioMEMS Devices Product Portfolios and Specifications
13.11.3 Capitalbio Corporation BioMEMS Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Capitalbio Corporation Main Business Overview
13.11.5 Capitalbio Corporation Latest Developments
13.12 Teledyne Technologies
13.12.1 Teledyne Technologies Company Information
13.12.2 Teledyne Technologies BioMEMS Devices Product Portfolios and Specifications
13.12.3 Teledyne Technologies BioMEMS Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Teledyne Technologies Main Business Overview
13.12.5 Teledyne Technologies Latest Developments
13.13 Silicon Microstructures
13.13.1 Silicon Microstructures Company Information
13.13.2 Silicon Microstructures BioMEMS Devices Product Portfolios and Specifications
13.13.3 Silicon Microstructures BioMEMS Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Silicon Microstructures Main Business Overview
13.13.5 Silicon Microstructures Latest Developments
13.14 Micralyne Inc
13.14.1 Micralyne Inc Company Information
13.14.2 Micralyne Inc BioMEMS Devices Product Portfolios and Specifications
13.14.3 Micralyne Inc BioMEMS Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Micralyne Inc Main Business Overview
13.14.5 Micralyne Inc Latest Developments
13.15 Knowles Corporation
13.15.1 Knowles Corporation Company Information
13.15.2 Knowles Corporation BioMEMS Devices Product Portfolios and Specifications
13.15.3 Knowles Corporation BioMEMS Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Knowles Corporation Main Business Overview
13.15.5 Knowles Corporation Latest Developments
13.16 Integrated Sensing Systems
13.16.1 Integrated Sensing Systems Company Information
13.16.2 Integrated Sensing Systems BioMEMS Devices Product Portfolios and Specifications
13.16.3 Integrated Sensing Systems BioMEMS Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Integrated Sensing Systems Main Business Overview
13.16.5 Integrated Sensing Systems Latest Developments
14 Research Findings and Conclusion